These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages. Radolf JD, Arndt LL, Akins DR, Curetty LL, Levi ME, Shen Y, Davis LS, Norgard MV. J Immunol; 1995 Mar 15; 154(6):2866-77. PubMed ID: 7876555 [Abstract] [Full Text] [Related]
3. Activation of human monocytic cells by Borrelia burgdorferi and Treponema pallidum is facilitated by CD14 and correlates with surface exposure of spirochetal lipoproteins. Sellati TJ, Bouis DA, Caimano MJ, Feulner JA, Ayers C, Lien E, Radolf JD. J Immunol; 1999 Aug 15; 163(4):2049-56. PubMed ID: 10438943 [Abstract] [Full Text] [Related]
6. Insertion of fluorescent fatty acid probes into the outer membranes of the pathogenic spirochaetes Treponema pallidum and Borrelia burgdorferi. Cox DL, Radolf JD. Microbiology (Reading); 2001 May 15; 147(Pt 5):1161-1169. PubMed ID: 11320119 [Abstract] [Full Text] [Related]
7. Lipoproteins of Borrelia burgdorferi and Treponema pallidum activate cachectin/tumor necrosis factor synthesis. Analysis using a CAT reporter construct. Radolf JD, Norgard MV, Brandt ME, Isaacs RD, Thompson PA, Beutler B. J Immunol; 1991 Sep 15; 147(6):1968-74. PubMed ID: 1890308 [Abstract] [Full Text] [Related]
8. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytic cells via a CD14-dependent pathway distinct from that used by lipopolysaccharide. Sellati TJ, Bouis DA, Kitchens RL, Darveau RP, Pugin J, Ulevitch RJ, Gangloff SC, Goyert SM, Norgard MV, Radolf JD. J Immunol; 1998 Jun 01; 160(11):5455-64. PubMed ID: 9605148 [Abstract] [Full Text] [Related]
9. Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B. Norgard MV, Arndt LL, Akins DR, Curetty LL, Harrich DA, Radolf JD. Infect Immun; 1996 Sep 01; 64(9):3845-52. PubMed ID: 8751937 [Abstract] [Full Text] [Related]
10. Solid-phase synthesis of biologically active lipopeptides as analogs for spirochetal lipoproteins. DeOgny L, Pramanik BC, Arndt LL, Jones JD, Rush J, Slaughter CA, Radolf JD, Norgard MV. Pept Res; 1994 Sep 01; 7(2):91-7. PubMed ID: 8012126 [Abstract] [Full Text] [Related]